Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016
|
|
- Madison Hunt
- 5 years ago
- Views:
Transcription
1 Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016
2 Congestive Heart Failure (Heart Failure) - Pipeline Review, H Sector Publishing Intelligence Limited (SPi) has been marketing business and market research reports from selected publishers for over five years. SPi offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, SPi is well positioned to coordinate our customers' orders sourced from over 30 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or office@sectorpublishing.com 2
3 Congestive Heart Failure (Heart Failure) - Pipeline Review, H Congestive Heart Failure (Heart Failure) - Pipeline Review, H Summary Global Markets Direct s, Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016, provides an overview of the Congestive Heart Failure (Heart Failure) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Congestive Heart Failure (Heart Failure), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects. Global Markets Direct s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the global therapeutic landscape of Congestive Heart Failure (Heart Failure) - The report reviews pipeline therapeutics for Congestive Heart Failure (Heart Failure) by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Congestive Heart Failure (Heart Failure) therapeutics and enlists all their major and minor projects - The report assesses Congestive Heart Failure (Heart Failure) therapeutics based on drug target, 3
4 mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Congestive Heart Failure (Heart Failure) Reasons to buy - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Congestive Heart Failure (Heart Failure) - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it s most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Congestive Heart Failure (Heart Failure) pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Additional Details Publisher : Global Markets Direct Reference : GMDHC8423IDB Number of Pages : 393 Report Format : PDF Publisher Information : Welcome to Global Markets Direct The home of leading edge research and analysis. The Global Markets Direct brand features thousands of high quality company and market research reports across a broad range of industries. Browse or search our collection of reports today to access the latest in business intelligence from some of the world s leading publishers. 4
5 Table Of Contents for Congestive Heart Failure (Heart Failure) - Pipeline Review, H Table of Contents Table of Contents 2 List of Tables 8 List of Figures 10 Introduction 11 Global Markets Direct Report Coverage 11 Congestive Heart Failure (Heart Failure) Overview 12 Therapeutics Development 13 Pipeline Products for Congestive Heart Failure (Heart Failure) - Overview 13 Pipeline Products for Congestive Heart Failure (Heart Failure) - Comparative Analysis 14 Congestive Heart Failure (Heart Failure) - Therapeutics under Development by Companies 15 Congestive Heart Failure (Heart Failure) - Therapeutics under Investigation by Universities/Institutes 21 Congestive Heart Failure (Heart Failure) - Pipeline Products Glance 23 Late Stage Products 23 Clinical Stage Products 24 Early Stage Products 25 Unknown Stage Products 26 Congestive Heart Failure (Heart Failure) - Products under Development by Companies 27 Congestive Heart Failure (Heart Failure) - Products under Investigation by Universities/Institutes 34 Congestive Heart Failure (Heart Failure) - Companies Involved in Therapeutics Development 36 Amgen Inc. 36 AnGes MG, Inc. 37 Araim Pharmaceuticals, Inc. 38 ARCA biopharma, Inc. 39 Ascelegen Therapeutics, Inc. 40 Asterias Biotherapeutics, Inc. 41 Athersys, Inc. 42 Bayer AG 43 BEAT BioTherapeutics Corp. 44 BioCardia, Inc. 45 Bristol-Myers Squibb Company 46 Capricor Therapeutics, Inc. 47 Cell Therapy Limited 48 Celyad SA 49 Eli Lilly and Company 50 FibroGen, Inc. 51 GlaxoSmithKline Plc 52 Glucox Biotech AB 53 Heart Metabolics Limited 54 Hemostemix Ltd 55 Innopharmax Inc. 56 Jiangsu Hengrui Medicine Co., Ltd. 57 Juventas Therapeutics, Inc. 58 5
6 La Jolla Pharmaceutical Company 59 Laboratoires Pierre Fabre SA 60 Lead Discovery Center GmbH 61 Lee's Pharmaceutical Holdings Limited 62 Les Laboratoires Servier SAS 63 Lonestar Heart, Inc. 64 Mast Therapeutics, Inc. 65 Merck & Co., Inc. 66 Mesoblast Limited 67 miragen Therapeutics, Inc. 68 MorphoSys AG 69 NanoCor Therapeutics, Inc. 70 Neurocrine Biosciences, Inc. 71 Novartis AG 72 Nuo Therapeutics, Inc. 73 Ono Pharmaceutical Co., Ltd. 74 Palatin Technologies, Inc. 75 Pfizer Inc. 76 PharmaIN Corporation 77 PhaseBio Pharmaceuticals, Inc. 78 Pluristem Therapeutics Inc. 79 Quantum Genomics SA 80 Recardio GmbH 81 RedHill Biopharma Ltd. 82 Renova Therapeutics Inc 83 scpharmaceuticals Inc 84 Stealth BioTherapeutics Inc. 85 Stemedica Cell Technologies, Inc. 86 Target Heart Biotec Srl 87 Theravance Biopharma, Inc. 88 TiGenix NV 89 Torrent Pharmaceuticals Limited 90 Trevena, Inc. 91 U.S. Stem Cell, Inc. 92 Vichem Chemie Research Ltd. 93 Vicore Pharma AB 94 Zensun (Shanghai) Sci & Tech Co., Ltd. 95 Congestive Heart Failure (Heart Failure) - Therapeutics Assessment 96 Assessment by Monotherapy Products 96 Assessment by Combination Products 97 Assessment by Target 98 Assessment by Mechanism of Action 104 Assessment by Route of Administration 110 Assessment by Molecule Type 112 Drug Profiles 114 (sacubitril + valsartan) - Drug Profile 114 AAVS-100A1 - Drug Profile 119 ACP-01 - Drug Profile 121 AdipoCell - Drug Profile 124 aladorian sodium - Drug Profile 127 ALD Drug Profile 129 6
7 AMG Drug Profile 131 AntimiR-199a - Drug Profile 132 ARX Drug Profile 133 BAY Drug Profile 134 BBR-12 - Drug Profile 135 beperminogene perplasmid - Drug Profile 136 BMS Drug Profile 141 bucindolol hydrochloride - Drug Profile 142 C-21 - Drug Profile 149 C3BSCQR-1 - Drug Profile 151 CAP Drug Profile 156 Carfostin - Drug Profile 161 carvedilol CR - Drug Profile 162 carvedilol phosphate CR - Drug Profile 164 cenderitide - Drug Profile 165 cibinetide - Drug Profile 168 CLR Drug Profile 171 CM-1 - Drug Profile 172 CTX Drug Profile 174 Drug to Inhibit Calpain for Heart Failure - Drug Profile 176 Drug to Inhibit Phosphoinositide 3-Kinase Gamma for Heart Failure - Drug Profile 177 Drugs to Inhibit mir-425 for Hypertension and Heart Failure - Drug Profile 178 ECR-A1 - Drug Profile 179 elamipretide - Drug Profile 180 enalapril maleate - Drug Profile 187 F Drug Profile 188 FG Drug Profile 189 FG Drug Profile 190 furosemide - Drug Profile 191 GDF-11 - Drug Profile 193 Gene Therapy to Activate Adenylate Cyclase Type 6 for Heart Failure - Drug Profile 194 Gene Therapy to Activate GLP-1 for Congestive Heart Failure - Drug Profile 195 Gene Therapy to Activate UCn 2 for Congestive Heart Failure - Drug Profile 196 Gene Therapy to Inhibit GRK2 for Heart Failure - Drug Profile 197 Gene Therapy to Inhibit Mef2 for Heart Failure - Drug Profile 198 Gene Therapy to Target makapbeta for Heart Failure - Drug Profile 199 GSK Drug Profile 200 istaroxime - Drug Profile 201 ITD-1 - Drug Profile 203 ivabradine hydrochloride - Drug Profile 204 ivabradine hydrochloride SR - Drug Profile 206 JVS Drug Profile 207 KBP Drug Profile 212 L Drug Profile 213 MGN Drug Profile 214 milrinone ER - Drug Profile 216 Monoclonal Antibody to Inhibit Periostin1 for Congestive Heart Failure - Drug Profile 217 MP Drug Profile 218 MPC-150IM - Drug Profile 219 MRS Drug Profile 224 MyoCell - Drug Profile 225 7
8 MyoCell SDF-1 - Drug Profile 227 NBI Drug Profile 228 neladenoson bialanate - Drug Profile 229 Neucardin - Drug Profile 230 NM Drug Profile 233 NPA-7 - Drug Profile 234 Oligonucleotides for Heart Failure - Drug Profile 235 omecamtiv mecarbil MR - Drug Profile 236 ONO Drug Profile 243 PB Drug Profile 244 Peptide to Agonize Apelin Receptor for Diabetes and Heart Failure - Drug Profile 246 Peptides to Inhibit MyBP-C/Myosin Interaction for Heart Failure - Drug Profile 247 perhexiline maleate - Drug Profile 248 PF Drug Profile 250 PHIN Drug Profile 261 PL Drug Profile 262 PLX-PAD - Drug Profile 264 poloxamer - Drug Profile 273 pyroglutaminated serpinin - Drug Profile 275 QGC Drug Profile 276 REC-02 - Drug Profile 277 Recombinant Protein for Congestive Heart Failure - Drug Profile 278 rivaroxaban - Drug Profile 279 RT Drug Profile 293 RT Drug Profile 294 RT Drug Profile 295 RT Drug Profile 296 ruboxistaurin - Drug Profile 297 S Drug Profile 299 serelaxin - Drug Profile 300 serpinin - Drug Profile 304 SG Drug Profile 305 sildenafil citrate - Drug Profile 306 Small Molecule for Target RhoGEF12 for Cardiovascular Disease - Drug Profile 308 Small Molecule to Inhibit BMP for Cardiovascular, CNS, Oncology and Musculoskeletal Disorders - Drug Profile 309 Small Molecule to Inhibit NOX-4 for Heart Failure - Drug Profile 310 Small Molecule to Inhibit ROMK for Hypertension and Heart Failure - Drug Profile 311 Small Molecules for Chronic Heart Failure - Drug Profile 312 Small Molecules for Diabetes and Congestive Heart Failure - Drug Profile 313 Small Molecules for Diastolic Heart Failure - Drug Profile 314 Small Molecules to Activate RXFP1 for Heart Failure and Fibrosis - Drug Profile 315 Small Molecules to Inhibit CaMKII for Arrhythmias and Heart Failure - Drug Profile 316 Small molecules to Inhibit CYP11B2 for Cardiovascular Diseases - Drug Profile 317 Small Molecules to Inhibit G betagamma for Heart Failure, Hypertension, Inflammation and Pain - Drug Profile 318 Small Molecules to Inhibit GRK2 for Heart Failure - Drug Profile 319 Small Molecules to Inhibit PDE4 for Heart Failure - Drug Profile 320 Small Molecules to Inhibit PDE5 for Cardiovascular Disease - Drug Profile 321 Small Molecules to Taregt Beta 2 Adrenergic Receptor and Cannabinoid Receptor for Oncology, Respiratory and Cardiovascular Disorders - Drug Profile 322 8
9 sodium nitrite - Drug Profile 323 SP Drug Profile 326 Stem Cell Therapy for Bacterial Sepsis, Cardiovascular Disease, CNS Disorders, Metabolic Disorders, Respiratory Disease and Toxicology - Drug Profile 327 Stem Cell Therapy for CNS Disorders, Rheumatoid Arthritis, Osteoarthritis, Bronchopulmonary Dysplasia and Heart Failure - Drug Profile 332 Stem Cell Therapy for Congestive Heart Failure and Kawasaki Disease - Drug Profile 333 Stem Cell Therapy for Heart failure - Drug Profile 334 Stem Cell Therapy for Heart Failure - Drug Profile 335 Stem Cell Therapy for Myocardial Infarction and Heart Failure - Drug Profile 336 Synthetic Peptide to Activate Erythropoietin Receptor for Cardiovascular Diseases - Drug Profile 337 Synthetic Peptide to Agonise Beta 2 Adrenergic Receptor for Congestive Heart Failure - Drug Profile 338 Synthetic Peptide to Agonize Guanylate Cyclase A for Cardiovascular Disorders - Drug Profile 339 TD Drug Profile 340 TR-4 - Drug Profile 342 TRC Drug Profile 343 TRV Drug Profile 345 ularitide - Drug Profile 346 VCP Drug Profile 348 vepoloxamer - Drug Profile 349 vericiguat - Drug Profile 357 Xcel-hCardP - Drug Profile 358 XEN Drug Profile 359 Congestive Heart Failure (Heart Failure) - Dormant Projects 360 Congestive Heart Failure (Heart Failure) - Discontinued Products 370 Congestive Heart Failure (Heart Failure) - Product Development Milestones 372 Featured News & Press Releases 372 Appendix 383 Methodology 383 Coverage 383 Secondary Research 383 Primary Research 383 Expert Panel Validation 383 Contact Us 383 Disclaimer 384 9
10 List Of Tables in Congestive Heart Failure (Heart Failure) - Pipeline Review, H List of Tables Number of Products under Development for Congestive Heart Failure (Heart Failure), H Number of Products under Development for Congestive Heart Failure (Heart Failure) - Comparative Analysis, H Number of Products under Development by Companies, H Number of Products under Development by Companies, H (Contd..1) 26 Number of Products under Development by Companies, H (Contd..2) 27 Number of Products under Development by Companies, H (Contd..3) 28 Number of Products under Development by Companies, H (Contd..4) 29 Number of Products under Investigation by Universities/Institutes, H Comparative Analysis by Late Stage Development, H Comparative Analysis by Clinical Stage Development, H Comparative Analysis by Early Stage Development, H Comparative Analysis by Unknown Stage Development, H Products under Development by Companies, H Products under Development by Companies, H (Contd..1) 37 Products under Development by Companies, H (Contd..2) 38 Products under Development by Companies, H (Contd..3) 39 Products under Development by Companies, H (Contd..4) 40 Products under Development by Companies, H (Contd..5) 41 Products under Development by Companies, H (Contd..6) 42 Products under Investigation by Universities/Institutes, H Products under Investigation by Universities/Institutes, H (Contd..1) 44 Congestive Heart Failure (Heart Failure) - Pipeline by Amgen Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by AnGes MG, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Araim Pharmaceuticals, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by ARCA biopharma, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Ascelegen Therapeutics, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Asterias Biotherapeutics, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Athersys, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Bayer AG, H Congestive Heart Failure (Heart Failure) - Pipeline by BEAT BioTherapeutics Corp., H Congestive Heart Failure (Heart Failure) - Pipeline by BioCardia, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Bristol-Myers Squibb Company, H Congestive Heart Failure (Heart Failure) - Pipeline by Capricor Therapeutics, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Cell Therapy Limited, H Congestive Heart Failure (Heart Failure) - Pipeline by Celyad SA, H Congestive Heart Failure (Heart Failure) - Pipeline by Eli Lilly and Company, H Congestive Heart Failure (Heart Failure) - Pipeline by FibroGen, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by GlaxoSmithKline Plc, H Congestive Heart Failure (Heart Failure) - Pipeline by Glucox Biotech AB, H Congestive Heart Failure (Heart Failure) - Pipeline by Heart Metabolics Limited, H Congestive Heart Failure (Heart Failure) - Pipeline by Hemostemix Ltd, H Congestive Heart Failure (Heart Failure) - Pipeline by Innopharmax Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H Congestive Heart Failure (Heart Failure) - Pipeline by Juventas Therapeutics, Inc., H
11 Congestive Heart Failure (Heart Failure) - Pipeline by La Jolla Pharmaceutical Company, H Congestive Heart Failure (Heart Failure) - Pipeline by Laboratoires Pierre Fabre SA, H Congestive Heart Failure (Heart Failure) - Pipeline by Lead Discovery Center GmbH, H Congestive Heart Failure (Heart Failure) - Pipeline by Lee's Pharmaceutical Holdings Limited, H Congestive Heart Failure (Heart Failure) - Pipeline by Les Laboratoires Servier SAS, H Congestive Heart Failure (Heart Failure) - Pipeline by Lonestar Heart, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Mast Therapeutics, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Merck & Co., Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Mesoblast Limited, H Congestive Heart Failure (Heart Failure) - Pipeline by miragen Therapeutics, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by MorphoSys AG, H Congestive Heart Failure (Heart Failure) - Pipeline by NanoCor Therapeutics, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Neurocrine Biosciences, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Novartis AG, H Congestive Heart Failure (Heart Failure) - Pipeline by Nuo Therapeutics, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Ono Pharmaceutical Co., Ltd., H Congestive Heart Failure (Heart Failure) - Pipeline by Palatin Technologies, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Pfizer Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by PharmaIN Corporation, H Congestive Heart Failure (Heart Failure) - Pipeline by PhaseBio Pharmaceuticals, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Pluristem Therapeutics Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Quantum Genomics SA, H Congestive Heart Failure (Heart Failure) - Pipeline by Recardio GmbH, H Congestive Heart Failure (Heart Failure) - Pipeline by RedHill Biopharma Ltd., H Congestive Heart Failure (Heart Failure) - Pipeline by Renova Therapeutics Inc, H Congestive Heart Failure (Heart Failure) - Pipeline by scpharmaceuticals Inc, H Congestive Heart Failure (Heart Failure) - Pipeline by Stealth BioTherapeutics Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Stemedica Cell Technologies, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Target Heart Biotec Srl, H Congestive Heart Failure (Heart Failure) - Pipeline by Theravance Biopharma, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by TiGenix NV, H Congestive Heart Failure (Heart Failure) - Pipeline by Torrent Pharmaceuticals Limited, H Congestive Heart Failure (Heart Failure) - Pipeline by Trevena, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by U.S. Stem Cell, Inc., H Congestive Heart Failure (Heart Failure) - Pipeline by Vichem Chemie Research Ltd., H Congestive Heart Failure (Heart Failure) - Pipeline by Vicore Pharma AB, H Congestive Heart Failure (Heart Failure) - Pipeline by Zensun (Shanghai) Sci & Tech Co., Ltd., H Assessment by Monotherapy Products, H Assessment by Combination Products, H Number of Products by Stage and Target, H Number of Products by Stage and Mechanism of Action, H Number of Products by Stage and Route of Administration, H Number of Products by Stage and Molecule Type, H Congestive Heart Failure (Heart Failure) - Dormant Projects, H Congestive Heart Failure (Heart Failure) - Dormant Projects (Contd..1), H Congestive Heart Failure (Heart Failure) - Dormant Projects (Contd..2), H Congestive Heart Failure (Heart Failure) - Dormant Projects (Contd..3), H Congestive Heart Failure (Heart Failure) - Dormant Projects (Contd..4), H Congestive Heart Failure (Heart Failure) - Dormant Projects (Contd..5), H
12 Congestive Heart Failure (Heart Failure) - Dormant Projects (Contd..6), H Congestive Heart Failure (Heart Failure) - Dormant Projects (Contd..7), H Congestive Heart Failure (Heart Failure) - Dormant Projects (Contd..8), H Congestive Heart Failure (Heart Failure) - Dormant Projects (Contd..9), H Congestive Heart Failure (Heart Failure) - Discontinued Products, H Congestive Heart Failure (Heart Failure) - Discontinued Products (Contd..1), H
13 List Of Figures, Charts and Diagrams in Congestive Heart Failure (Heart Failure) - Pipeline Review, H List of Figures Number of Products under Development for Congestive Heart Failure (Heart Failure), H Number of Products under Development for Congestive Heart Failure (Heart Failure) - Comparative Analysis, H Number of Products under Development by Companies, H Number of Products under Investigation by Universities/Institutes, H Comparative Analysis by Late Stage Development, H Comparative Analysis by Clinical Stage Development, H Comparative Analysis by Early Stage Products, H Assessment by Monotherapy Products, H Number of Products by Top 10 Targets, H Number of Products by Stage and Top 10 Targets, H Number of Products by Top 10 Mechanism of Actions, H Number of Products by Stage and Top 10 Mechanism of Actions, H Number of Products by Top 10 Routes of Administration, H Number of Products by Stage and Top 10 Routes of Administration, H Number of Products by Top 10 Molecule Types, H Number of Products by Stage and Top 10 Molecule Types, H
14 How to Buy... Congestive Heart Failure (Heart Failure) - Pipeline Review, H Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at office@sectorpublishing.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $2000 Single User Price $4000 Site License Price $6000 Global License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 14
Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016
Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016 Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016 Sector Publishing Intelligence Limited (SPi) has been marketing business
More informationDravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H2 2016
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H2 2016 Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H2 2016 BioPortfolio has been marketing business
More informationDiabetic Neuropathy - Pipeline Review, H1 2017
Diabetic Neuropathy - Pipeline Review, H1 2017 Diabetic Neuropathy - Pipeline Review, H1 2017 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen
More informationCognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015 Cognitive Impairment Associated
More informationAtrial Fibrillation - Pipeline Review, H1 2017
Report Information More information from: https://www.wiseguyreports.com/reports/1095866-atrial-fibrillation-pipeline-review-h1-2017 Atrial Fibrillation - Pipeline Review, H1 2017 Report / Search Code:
More informationChemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016 Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016 BioPortfolio has been marketing business
More informationMild Cognitive Impairment - Pipeline Review, H1 2017
Report Information More information from: https://www.wiseguyreports.com/reports/1184709-mild-cognitive-impairment-pipeline-review-h1-2017 Mild Cognitive Impairment - Pipeline Review, H1 2017 Report /
More informationHuman Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016
Report Information More information from: https://www.wiseguyreports.com/reports/685904-human-papillomavirus-hpv-associated-cancerpipeline-review-h2-2016 Human Papillomavirus (HPV) Associated Cancer -
More informationAdrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder- Addison Complex) - Pipeline Review, H2 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H2 2016 Adrenoleukodystrophy
More informationSickle-cell Anemia Therapeutics Market in the US
Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Sector Publishing Intelligence Limited (SPi) has been marketing business and market
More informationDiabetic Peripheral Neuropathy - Pipeline Review, H2 2017
Published on Drug Pipeline (https://www.drugpipeline.net) Home > Diabetic Peripheral Neuropathy - Pipeline Review, H2 2017 Diabetic Peripheral Neuropathy - Pipeline Review, H2 2017 Publication ID: GMD0717059
More informationDravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015 Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015 BioPortfolio
More informationNon Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018
Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase
More informationSpinal Cord Injury - Pipeline Review, H2 2016
Spinal Cord Injury - Pipeline Review, H2 2016 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service
More informationIrritable Bowel Syndrome - Pipeline Review, H2 2016
Report Information More information from: https://www.wiseguyreports.com/reports/752817-irritable-bowel-syndrome-pipeline-review-h2-2016 Irritable Bowel Syndrome - Pipeline Review, H2 2016 Report / Search
More informationCompetitor Analysis: TGF-? Inhibitors for Modulation of the Tumor Microenvironment
Competitor Analysis: TGF-? Inhibitors for Modulation of the Tumor Microenvironment Competitor Analysis: TGF-? Inhibitors for Modulation of the Tumor Microenvironment BioPortfolio has been marketing business
More informationCompetitor Analysis: IDO & TDO Inhibitors for Modulation of the Tumor Microenvironment
Competitor Analysis: IDO & TDO Inhibitors for Modulation of the Tumor Microenvironment Competitor Analysis: IDO & TDO Inhibitors for Modulation of the Tumor Microenvironment BioPortfolio has been marketing
More informationH. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review
H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports
More informationIrritable Bowel Syndrome - Pipeline Review, H2 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Irritable Bowel Syndrome - Pipeline Review, H2 2016 Irritable Bowel Syndrome - Pipeline Review, H2 2016 Publication
More informationPoland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022
Poland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 Poland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton
More informationRussia Cardiac Assist Devices Market Outlook to 2021
Russia Cardiac Assist Devices Market Outlook to 2021 Russia Cardiac Assist Devices Market Outlook to 2021 BioPortfolio has been marketing business and market research reports from selected publishers for
More informationBariatric Surgery Devices - North America Analysis and Market Forecasts
Bariatric Surgery Devices - North America Analysis and Market Forecasts Bariatric Surgery Devices - North America Analysis and Market Forecasts BioPortfolio has been marketing business and market research
More informationNorth America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021
North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 BioPortfolio has been marketing business and market research
More informationU.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon),
U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin,
More informationCochlear Implants - Medical Devices Pipeline Assessment, 2016
Cochlear Implants - Medical Devices Pipeline Assessment, 2016 Cochlear Implants - Medical Devices Pipeline Assessment, 2016 BioPortfolio has been marketing business and market research reports from selected
More informationSukhjit Starch And Chemicals Ltd - Company Capsule
Sukhjit Starch And Chemicals Ltd - Company Capsule Sukhjit Starch And Chemicals Ltd - Company Capsule The Business Research Store is run by Sector Publishing Intelligence Ltd. SPi has been selling professional
More informationRecurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016 Recurrent Glioblastoma Multiforme (GBM) - Pipeline
More informationAtopic Dermatitis - Japan Drug Forecast and Market Analysis to 2024
Atopic Dermatitis - Japan Drug Forecast and Market Analysis to 2024 Atopic Dermatitis - Japan Drug Forecast and Market Analysis to 2024 BioPortfolio has been marketing business and market research reports
More informationPercutaneous Transluminal Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016
Percutaneous Transluminal Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016 Percutaneous Transluminal Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016 BioPortfolio has been
More informationChina Silymarin Industry Overview,
China Silymarin Industry Overview, 2017-2021 China Silymarin Industry Overview, 2017-2021 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen
More informationAesthetic Laser - Medical Devices Pipeline Assessment, 2016
Aesthetic Laser - Medical Devices Pipeline Assessment, 2016 Aesthetic Laser - Medical Devices Pipeline Assessment, 2016 BioPortfolio has been marketing business and market research reports from selected
More informationCOPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global
COPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global Opportunity Analysis and Industry Forecasts, 2015-2022 COPD and
More informationInfertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer,
Infertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer, Workstation), Technology (AI, Gamete Donation, IVF, ICSI,
More informationHIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse
HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs),
More informationThe National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare
More informationDental Floss (Oral Hygiene) Market in South Korea - Outlook to 2020: Market Size, Growth and Forecast Analytics
Dental Floss (Oral Hygiene) Market in South Korea - Outlook to 2020: Market Size, Growth and Forecast Analytics Dental Floss (Oral Hygiene) Market in South Korea - Outlook to 2020: Market Size, Growth
More informationAlpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic
Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast
More informationTandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile
Tandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile Tandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business
More informationSilica Fume Market by Application (Building Construction, Marine Structure Construction, Oil & Gas Well Grouting, Nuclear Power Plant Construction,
Silica Fume Market by Application (Building Construction, Marine Structure Construction, Oil & Gas Well Grouting, Nuclear Power Plant Construction, Chemical Production Facilities Construction, by Geography
More informationGlobal Insulin Pumps Market
Global Insulin Pumps Market 2016-2020 Global Insulin Pumps Market 2016-2020 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio
More informationGlobal In-Vitro-Fertilization Market: Trends and Opportunities ( )
Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019) Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019) BioPortfolio has been marketing business and market
More informationAustralia Dental Implants And Prosthetics Market By Implant Material (Titanium, Zirconium), Prosthetic Product (Bridges, Crowns, Dentures), Denture
Australia Dental Implants And Prosthetics Market By Implant Material (Titanium, Zirconium), Prosthetic Product (Bridges, Crowns, Dentures), Denture Type (Partial,Complete), and Abutment Type (Definitive,
More informationImplantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter
Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), and Cardiac Resynchronization
More informationInsulin Pens - Medical Devices Pipeline Assessment, 2016
Insulin Pens - Medical Devices Pipeline Assessment, 2016 Insulin Pens - Medical Devices Pipeline Assessment, 2016 Sector Publishing Intelligence Limited (SPi) has been marketing business and market research
More informationUrinary Incontinence Products Market in Europe
Urinary Incontinence Products Market in Europe 2015-2019 Urinary Incontinence Products Market in Europe 2015-2019 BioPortfolio has been marketing business and market research reports from selected publishers
More informationPharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market
More informationGlobal Avian Influenza Vaccines Market Data Survey Report 2025
Global Avian Influenza Vaccines Market Data Survey Report 2025 Global Avian Influenza Vaccines Market Data Survey Report 2025 BioPortfolio has been marketing business and market research reports from selected
More informationEUROPE INFERTILITY (TESTING AND TREATMENT) MARKET FORECAST
EUROPE INFERTILITY (TESTING AND TREATMENT) MARKET FORECAST 2017-2025 EUROPE INFERTILITY (TESTING AND TREATMENT) MARKET FORECAST 2017-2025 BioPortfolio has been marketing business and market research reports
More informationPoultry Diagnostics Market by Test (ELISA, PCR) Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Pasteurellosis,
Poultry Diagnostics Market by Test (ELISA, PCR) Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Pasteurellosis, Encephalomyelitis, Infectious Bronchitis), Service (Virology, Bacteriology,
More informationGlobal Vitamin Ingredients Market
Global Vitamin Ingredients Market 2016-2020 Global Vitamin Ingredients Market 2016-2020 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years.
More informationStructural Heart Devices Market by Product (Structural Heart Repair Devices and Replacement Valves), Age Group (Pediatric and Adult), and Indication
Structural Heart Devices Market by Product (Structural Heart Repair Devices and Replacement Valves), Age Group (Pediatric and Adult), and Indication (Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO),
More informationProton Therapy Market Outlook - Global Analysis
Proton Therapy Market Outlook - Global Analysis Proton Therapy Market Outlook - Global Analysis BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen
More informationPharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024
PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024 PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024 BioPortfolio has been marketing business and market research
More informationInvisible Orthodontics Market in China
Invisible Orthodontics Market in China 2016-2020 Invisible Orthodontics Market in China 2016-2020 BioPortfolio has been marketing business and market research reports from selected publishers for over
More informationPhone: +44 (0) or BioPortfolio Limited
Europe Neuromodulation Devices Market by Procedure [Internal Stimulation (DBS, GES, SNS, SCS, VNS), and External Stimulation (TENS, TMS)], and by Geography Analysis & Forecast to 2019 Europe Neuromodulation
More informationHER2-Negative Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023
HER2-Negative Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 HER2-Negative Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 BioPortfolio has been marketing business and market
More informationOphthalmology Drug Development Pipeline Review, 2016
Ophthalmology Drug Development Pipeline Review, 2016 Ophthalmology Drug Development Pipeline Review, 2016 BioPortfolio has been marketing business and market research reports from selected publishers for
More informationUnited States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022
United States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 United States Proton Therapy Market (Actual & Potential), Patients Treated,
More informationRenal Denervation Catheters - Medical Devices Pipeline Assessment, 2017
Renal Denervation Catheters - Medical Devices Pipeline Assessment, 2017 Renal Denervation Catheters - Medical Devices Pipeline Assessment, 2017 The Business Research Store is run by Sector Publishing Intelligence
More informationAntifungal Drugs Market by Drug Type [Echinocandins {Caspofungin, Micafungin, Anidulafungin and Others}, Azoles {Imidazoles, Voricanazole, Thiazoles
Antifungal Drugs Market by Drug Type [Echinocandins {Caspofungin, Micafungin, Anidulafungin and Others}, Azoles {Imidazoles, Voricanazole, Thiazoles and Others}, Polyenes {Amphotericin B, Candicidin, Hamycin,
More informationGlobal Hepatitis B and C Diagnostics Market
Global Hepatitis B and C Diagnostics Market 2016-2020 Global Hepatitis B and C Diagnostics Market 2016-2020 BioPortfolio has been marketing business and market research reports from selected publishers
More informationOncology Pipeline Analytics
Oncology Pipeline Analytics Trials, Drug Classes, Indications, Correlations and Strategies Report Brochure O n c o l o g y P i p e l i n e A n a l y t i c s Greystone Research Associates is pleased to
More informationCystic Fibrosis: KOL Insight [2017]
Cystic Fibrosis: KOL Insight [2017] Cystic Fibrosis: KOL Insight [2017] BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio
More informationAsia-Pacific In-Vitro Fertilization (IVF) Services Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycles) and End Users
Asia-Pacific In-Vitro Fertilization (IVF) Services Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycles) and End Users (Fertility Clinics, Hospitals, Surgical Centres, and Clinical
More informationQiagen NV (QIA) - Product Pipeline Analysis, 2017 Update
Qiagen NV (QIA) - Product Pipeline Analysis, 2017 Update Qiagen NV (QIA) - Product Pipeline Analysis, 2017 Update Sector Publishing Intelligence Limited (SPi) has been marketing business and market research
More informationEOG Resources, Inc. Analysis Across the Oil and Gas Value Chain Report
EOG Resources, Inc. Analysis Across the Oil and Gas Value Chain Report EOG Resources, Inc. Analysis Across the Oil and Gas Value Chain Report Sector Publishing Intelligence Limited (SPi) has been marketing
More informationReport Information. Shoulder Replacement - Pipeline Review, 2015
Report Information Shoulder Replacement - Pipeline Review, 2015 Report / Search Code: WGR178241 Publish Date: 4 September, 2015 Report Price: 1-user PDF : $ 2500.0 Site PDF : $ 5000.0 Enterprise PDF :
More informationImplantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2016
Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2016 Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2016 BioPortfolio has been
More informationNoninvasive Glucose Monitors to 2022
Noninvasive Glucose Monitors to 2022 Devices, Technologies, Players and Prospects Report Prospectus Greystone Research associates N o n i n v a s i v e G l u c o s e M o n i t o r s t o 2 0 2 2 Greystone
More informationVascular Endothelial Growth Factor Inhibitor Market
May 2017 Report Id : REP-GB-3292 Status : Ongoing Category : Healthcare, Pharmaceuticals & Medical Devices 2015 Future Market Insights, All Rights Reserved About Future Market Insights Future Market Insights
More informationCardiac Assist Devices - Medical Devices Pipeline Assessment, 2015
Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2015 Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2015 BioPortfolio has been marketing business and market research reports
More informationChina Oral Hypoglyceimic Agents (OHAs) Industry Report, Feb. 2011
China Oral Hypoglyceimic Agents (OHAs) Industry Report, 2010 Feb. 2011 This report Analyzes the status quo and prospect of Chinese OHAS Market. Related Products China Interventional Cardiovascular Device
More informationBRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
More informationBrochure More information from
Brochure More information from http://www.researchandmarkets.com/reports/2375238/ Breast Imaging Technologies Market (Digital Mammography,3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular
More informationChina Insulin Industry Report, Jan. 2011
China Insulin Industry Report, 2010 Jan. 2011 This report analyzes the status, competition pattern and development direction of the insulin industry Focuses on the operation and development prospect of
More informationOrally Inhaled Corticosteroids to 2022
Greystone Research Associates 1+603-595-4340 April 2015 Orally Inhaled Corticosteroids to 2022 Drugs, Devices, Markets and Forecasts Contents A Comprehensive Market Analysis Report Scope & Overview 2 Table
More informationTABLE OF CONTENTS 1 Table of Contents 2 Introduction 3 Key Marketed Products
TABLE OF CONTENTS 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Epidemiology 2.2 Symptoms 2.3 Etiology 2.4 Pathophysiology 2.5 Co-morbidities and Complications 2.6 Classification
More informationONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY
More informationNoninvasive Glucose Monitors Devices, Technologies, Players and Prospects
Report Prospectus Noninvasive Glucose Monitors Devices, Technologies, Players and Prospects 1 Improving Diabetes Management For diabetes patients, glucose monitoring is a way of life, a several-times-per-day
More informationBlood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595
Transparency Market Research Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample
More informationDry Eye Syndrome - Current and Future Players. GDHC1016FPR / Published May 2013
Dry Eye Syndrome - Current and Future Players GDHC1016FPR / Published May 2013 Executive Summary Significant growth is expected in the DES market from 2012-2022. GlobalData estimates 2012 DES therapeutic
More informationChanges from Third Quarter Flash Report for the Fiscal Year ending March 2015 announced on February 3, 2015 *1: Marketing authorization of Onoact 150
Annual Flash Report (unaudited) Fiscal Year ended March 31, 2015 Supplemental Information Status of Development Pipeline as of May 12, 2015 I. Main Pipelines Other than ONO-4538 ⅰ. Developments Status
More informationMedical Morphine Market Size, Share, Growth, Analysis, Trends, and Forescast to 2024 Hexa Research
Medical Morphine Market Size, Share, Growth, Analysis, Trends, and Forescast to 2024 Hexa Research Increasing use of the drug to relieve pain in cancer, arthritis and postoperative surgeries is expected
More informationUS pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health
US pharmaceutical market: trends, issues, forecast Doug Long Vice President Industry Relations IMS Health 2006 Strategic management review The World Pharmaceutical Market All reproduction rights, quotations,
More informationChina Human Vaccine Industry Report, May 2012
China Human Vaccine Industry Report, 2011-2012 May 2012 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight and
More informationChina Human Vaccine Industry Report, Jun. 2016
China Human Vaccine Industry Report, 2016-2020 Jun. 2016 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
More informationSAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB
Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0166BDB Publication Date: January 2013 GlobalData. This report is a licensed product
More informationJAK AND PI3K SIGNALING PATHWAY MARKETS
JAK AND PI3K SIGNALING PATHWAY MARKETS PHM168A April 2014 Shalini Shahani Dewan Project Analyst ISBN: 1-56965-793-9 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationTHE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
More informationDawson James Conference
Dawson James Conference October 2018 Forward-looking Statements Except for historical information, this presentation contains forward-looking statements, which reflect IMV s current expectations regarding
More informationSAMPLE. North America Propylene Industry Outlook to 2017 GDCH0615RDB/JAN 2013
- Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Reference Code: GDCH0615RDB Publication Date: January 2013 GlobalData. This report is a licensed product
More informationAsia-Pacific Bariatric Surgery Devices Market Outlook to 2020
Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List
More informationTamsulosin Hydrochloride 0.4 mg Capsule
Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule
More informationSPONSORSHIP & EXHIBITION 2019
SPONSORSHIP & EXHIBITION 2019 Cancer Conference 2019 Theme: Discovering Multidisciplinary Ways to Assess, Treat and Prevent Cancer World Conference on CANCER THERAPY AND ONCOLOGY January 30-31, 2019 Bangkok,
More informationTissue Engineering Market Analysis, Size, Share, Growth, Industry Trends and Forecast to Hexa Research
Tissue Engineering Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 - Hexa Research " The global tissue engineering market was valued to be around USD 23.2 billion in 2015 and
More informationeclinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research
eclinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " Projected to grow at a CAGR of around 12%, eclinical solutions market is expected to witness significant
More informationINCRETIN-BASED DRUGS: MARKETS FOR DIABETES THERAPIES AND DEVELOPING TREATMENTS
INCRETIN-BASED DRUGS: MARKETS FOR DIABETES THERAPIES AND DEVELOPING TREATMENTS PHM162A February 2015 Kim Lawson Project Analyst ISBN: 1-62296-047-5 BCC Research 49 Walnut Park, Building 2 Wellesley, MA
More informationChina Human Vaccine Industry Report, Mar. 2015
China Human Vaccine Industry Report, 2015-2018 Mar. 2015 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
More informationSAMPLE. Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0165BDB Publication Date: January 2013 GlobalData. This report
More information